Targeting the adenosinergic axis in cancer immunotherapy: Insights into A2A and A2B receptors and novel clinical combination strategies

腺苷酸 腺苷 癌症免疫疗法 癌症研究 肿瘤微环境 嘌呤能信号 免疫疗法 免疫系统 间质细胞 药理学 医学 信号转导 免疫学 血管生成 癌症 腺苷A2A受体 生物 腺苷A3受体 免疫检查点 癌细胞 T细胞 易普利姆玛 G蛋白偶联受体 功能选择性 腺苷A2B受体 过继性细胞移植 免疫抑制 腺苷受体 受体
作者
Iván Rodríguez-Pampín,Lucía González-Pico,Asier Selas,Antonio Andújar,Rubén Prieto‐Díaz,Eddy Sotelo
出处
期刊:Pharmacological Reviews [American Society for Pharmacology and Experimental Therapeutics]
卷期号:77 (6): 100092-100092 被引量:2
标识
DOI:10.1016/j.pharmr.2025.100092
摘要

The extracellular accumulation of adenosine is a central mechanism of immune evasion within the tumor microenvironment. Elevated adenosine levels-driven by hypoxia, chronic inflammation, and upregulated ectonucleotidase activity, primarily through ectonucleoside triphophate diphosphoydrolase 1 and ecto-5'-nucleotidase-induce profound immunosuppression and promote tumor progression. In this setting, adenosine acts mainly through 2 G protein-coupled receptors, the adenosine A2A receptor (A2AAR) and the adenosine A2B receptor (A2BAR), which modulate diverse immune and stromal cell populations. A2AAR signaling suppresses the effector activity of cytotoxic T lymphocytes and natural killer cells, whereas A2BAR activation exerts broader effects by amplifying myeloid-derived immunosuppression, driving stromal remodeling, and fostering angiogenesis and metastatic dissemination. This review provides a comprehensive overview of the distinct and converging roles of A2AAR and A2BAR in immune, stromal, and tumor compartments. We critically analyze current strategies for developing selective and dual A2AAR/A2BAR antagonists, with a focus on structure-activity relationships, scaffold optimization, and pharmacokinetic profiling. In addition, we examine ongoing clinical trials and emerging combination therapies involving A2AAR and A2BAR antagonists in conjunction with immune checkpoint inhibitors, adoptive cell therapies, enzymatic axis blockade, radiotherapy, and classical chemotherapy. We also underscore the therapeutic potential of dual A2AAR/A2BAR antagonists as a multitarget approach to counteract overlapping immunosuppressive mechanisms. Overall, targeting the adenosine axis-particularly through dual receptor blockade-represents a promising strategy for reprograming the tumor microenvironment, reinvigorating antitumor immunity, and improving the efficacy of cancer immunotherapy. SIGNIFICANCE STATEMENT: Adenosine signaling via adenosine A2A (A2AAR) and A2B (A2BAR) receptors plays a central role in tumor-induced immunosuppression, limiting the efficacy of cancer immunotherapy. This review provides an integrated analysis of A2AAR and A2BAR functions across immune and stromal compartments, summarizes current selective antagonists (A2AAR and A2BAR) and dual antagonists, and highlights compounds in clinical studies. Moreover, it discusses synergistic combination strategies that integrate adenosine blockade with complementary immunotherapeutic and conventional approaches to enhance antitumor responses.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
pingchangxinyi完成签到 ,获得积分10
1秒前
Xu完成签到,获得积分10
2秒前
Lune7发布了新的文献求助10
6秒前
pushengxiong发布了新的文献求助10
6秒前
阳阳完成签到 ,获得积分10
6秒前
7秒前
青帝完成签到 ,获得积分10
7秒前
芭乐王子完成签到 ,获得积分10
9秒前
brilliant完成签到 ,获得积分10
11秒前
fantasy的应助被369ninja采纳,获得10
12秒前
qianhuxinyu完成签到,获得积分10
15秒前
yy完成签到,获得积分10
15秒前
boymin2015完成签到 ,获得积分10
17秒前
科研通AI6.2的应助被cherry_mm采纳,获得30
18秒前
Mia123完成签到,获得积分10
20秒前
蜘蛛侠完成签到,获得积分10
24秒前
雪山大地发布了新的文献求助10
24秒前
咚咚大王完成签到 ,获得积分10
24秒前
博士完成签到 ,获得积分10
25秒前
几几完成签到,获得积分10
26秒前
cheng完成签到 ,获得积分10
27秒前
HJJHJH的应助被科研通管家采纳,获得30
28秒前
Owen的应助被科研通管家采纳,获得10
28秒前
长泽梓完成签到 ,获得积分20
29秒前
yli130发布了新的社区帖子
29秒前
SilentLight完成签到,获得积分10
30秒前
勤劳的夏天完成签到,获得积分10
32秒前
fantasy的应助被369ninja采纳,获得10
32秒前
35秒前
布曲完成签到 ,获得积分10
35秒前
38秒前
HQxiaohuan完成签到 ,获得积分10
39秒前
蓝精灵完成签到 ,获得积分10
39秒前
haralee完成签到 ,获得积分10
42秒前
Rui完成签到 ,获得积分10
43秒前
AKira完成签到 ,获得积分10
45秒前
Auster完成签到,获得积分10
46秒前
雪山大地发布了新的文献求助10
47秒前
小皮完成签到,获得积分10
47秒前
风中星月完成签到 ,获得积分10
48秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166550
求助须知:如何正确求助?哪些是违规求助? 9559535
关于积分的说明 21750720
捐赠科研通 7757357
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553523
邀请新用户注册赠送积分活动 2473904